CAS: 2097938-64-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide REF: 3D-XID93864CAS: 2097938-64-0 | Min. 95% | To inquire | Mon 27 Jan 25 |
 | CHK1 inhibitor REF: TM-T10793CAS: 2097938-64-0 | 98% | 1,374.00 €~3,739.00 € | Mon 17 Mar 25 |
![N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide](https://static.cymitquimica.com/products/3D/thumb/XID93864.jpg)
N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide
CAS:2097938-64-0
Gemcitabine is a cytotoxic drug that inhibits cell growth by binding to the ribonucleotide reductase …
Formula:
C17H21BrN4O
Purity:
Min. 95%
Molecular weight:
377.3 g/mol
Ref: 3D-XID93864
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
CHK1 inhibitor
CAS:2097938-64-0
CHK1 inhibitor (GDC-0575 analog) is a CHK1 inhibitor.
Formula:
C17H21BrN4O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
377.28
Ref: TM-T10793
| 25mg | 2,106.00 € | ||
| 50mg | 2,785.00 € | ||
| 100mg | 3,739.00 € |
Estimated delivery in United States, on Monday 17 Mar 2025
